Yesterday, March 15, 2016, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $710.84 to $145,264,601.52.

Highlighted Stocks Traded by Insiders:

Village Super Market (VLGEA) - FREE Research Report

Estate of Perry Sumas, who is Shareholder at Village Super Market, sold 3,700 shares at $24.29 on March 15, 2016. Following this transaction, the Shareholder owned 689,693 shares meaning that the stake was reduced by 0.53% with the 3,700-share transaction.

The shares most recently traded at $24.26, down $0.03, or 0.13% since the insider transaction. Historical insider transactions for Village Super Market go as follows:

  • 4-Week # shares sold: 17,278
  • 12-Week # shares sold: 62,390
  • 24-Week # shares sold: 144,402

The average volume for Village Super Market has been 31,300 shares per day over the past 30 days. Village Super Market has a market cap of $343.1 million and is part of the services sector and retail industry. Shares are down 8.01% year-to-date as of the close of trading on Tuesday.

Village Super Market, Inc. operates a chain of supermarkets in the United States. Its stores feature specialty departments, such as onsite bakery, an expanded delicatessen, natural and organic foods, ethnic and international foods, prepared foods, and pharmacies. The stock currently has a dividend yield of 4.12%. The company has a P/E ratio of 11.1. Currently, there are no analysts who rate Village Super Market a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLGEA - FREE

TheStreet Quant Ratings rates Village Super Market as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Village Super Market Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mohawk Industries (MHK) - FREE Research Report

Patton Rodney David, who is VP-Business Strategy and GC at Mohawk Industries, sold 550 shares at $186.00 on March 15, 2016. Following this transaction, the VP-Business Strategy and GC owned 9,363 shares meaning that the stake was reduced by 5.55% with the 550-share transaction.

The shares most recently traded at $181.97, down $4.03, or 2.21% since the insider transaction. Historical insider transactions for Mohawk Industries go as follows:

  • 4-Week # shares sold: 6,753
  • 12-Week # shares sold: 6,753
  • 24-Week # shares sold: 15,460

The average volume for Mohawk Industries has been 729,300 shares per day over the past 30 days. Mohawk Industries has a market cap of $13.7 billion and is part of the consumer goods sector and consumer durables industry. Shares are down 3.45% year-to-date as of the close of trading on Tuesday.

Mohawk Industries, Inc. designs, manufactures, sources, distributes, and markets flooring products for remodeling and new constructions of residential and commercial spaces worldwide. The company has a P/E ratio of 22.3. Currently, there are 6 analysts who rate Mohawk Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MHK - FREE

TheStreet Quant Ratings rates Mohawk Industries as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, compelling growth in net income, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Mohawk Industries Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Gilead (GILD) - FREE Research Report

Alton Gregg H, who is EVP, Corp & Med Affairs at Gilead, sold 5,000 shares at $90.00 on March 15, 2016. Following this transaction, the EVP, Corp & Med Affairs owned 147,090 shares meaning that the stake was reduced by 3.29% with the 5,000-share transaction.

The shares most recently traded at $90.45, up $0.45, or 0.5% since the insider transaction. Historical insider transactions for Gilead go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 20,046

The average volume for Gilead has been 12.6 million shares per day over the past 30 days. Gilead has a market cap of $123.6 billion and is part of the health care sector and drugs industry. Shares are down 11.61% year-to-date as of the close of trading on Tuesday.

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The stock currently has a dividend yield of 1.9%. The company has a P/E ratio of 7.6. Currently, there are 12 analysts who rate Gilead a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GILD - FREE

TheStreet Quant Ratings rates Gilead as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, attractive valuation levels, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Gilead Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.